admin

In recent weeks, QuantumScape (NYSE:QS) has made significant progress, improving the company’s outlook. Still, the valuation of QS stock remains very high, and the company continues to face major risks. Source: Michael Vi / Shutterstock.com Among these risks, as Morgan Stanley recently pointed out, are tough competition and the possibility that the production of electric
0 Comments
After an extended period of consolidation, Lucid (NASDAQ:LCID) stock has surged strongly in the last month. During this period, the stock has nearly doubled. Source: ggTravelDiary / Shutterstock.com Unlike the rally prior to the company’s merger with its SPAC , the recent gains have not been based on speculation. However, it would make sense to
0 Comments
A software rendering shows a recreation of Russia’s anti-satellite weapons test and the destruction of satellite Kosmos 1408, with the debris field in red. AGI The Pentagon called for a global halt to anti-satellite weapons testing on Wednesday, further decrying the practice after Russia’s destructive demonstration last month showered low Earth orbit with debris. “We
0 Comments
Here is what investors need to know about the next generation of the internet. Visit our website: https://www.zacks.com Visit our Stocktwits account: https://stocktwits.com/ZacksResearch Check out our weekly promotion: https://www.zacks.com/promo If you’re interested in our services, please check out Zacks Ultimate: https://www.zacks.com/ultimate/?adid=YOUTUBE&cid=sm-YOUTUBE
0 Comments
In this article CRM VRTX LEN Salesforce signage outside office building in New York. Scott Mlyn | CNBC Check out the companies making headlines in midday trading Wednesday: Allbirds — Allbirds shares sunk more than 13% after the shoe maker’s losses grew in the third quarter, even as its revenue rose from last year. The quarterly
0 Comments
The United Nations COP26 summit recently highlighted the fact that “human activities have caused around 1.1°C of global warming to date” and the “impacts are already being felt in every region.” Over the next few decades, countries need to work towards minimizing and potentially reversing the damage to the climate. Green energy stocks are therefore
0 Comments
Deciphera Pharmaceuticals (NASDAQ:DCPH) is a biotech company that develops drugs mainly for the treatment of cancer. Right now, DCPH stock shares are down nearly 85% year-to-date (YTD), at $7.70 as of the close of Nov. 29. Source: Iryna Imago / Shutterstock.com Of course, with Thanksgiving just over, it’s probably appropriate to note that I’m thankful for
0 Comments